In a recent development, L’Oreal USA, the renowned cosmetics giant, has reached a settlement in a patent dispute with a Christian religious order and the University of Massachusetts (UMass) concerning an innovative anti-aging skin cream. The parties involved, which include L’Oreal, UMass, and Carmel Laboratories, informed a Delaware federal court on Monday that they have amicably resolved their differences and intend to have the case dismissed by March 22.
Unfortunately, the specific details of the settlement have not been disclosed, and representatives from the involved parties have yet to provide further comments or information regarding the agreement. Carmel Laboratories functions as a subsidiary of Teresian Carmelites Inc, a religious community and monastery situated in Worcester, Massachusetts, under the leadership of former Catholic monk Dennis Wyrzykowski. It is within this context that Carmel and UMass, who hold the patents licensed by the Teresian Carmelite community for the production of their Easeamine anti-aging face cream, filed a lawsuit against L’Oreal in 2017.
The lawsuit alleged that L’Oreal’s RevitaLift moisturizer, as well as other undisclosed products from L’Oreal brands such as Maybelline and Lancome, infringed upon patents related to skin creams containing the chemical adenosine. According to the complaint, a representative from L’Oreal had engaged in discussions regarding the patented technology with its inventor, James Dobson, a member of the Teresian Carmelite community and a professor at UMass Medical School, back in 2003.
L’Oreal vehemently denied these allegations and successfully convinced the court to invalidate the patents in 2021. However, in a subsequent turn of events, the U.S. Court of Appeals for the Federal Circuit reinstated both the patents and the case in 2022.
